Connectyx Technologies Holdings Group, Inc. is looking for acquisition opportunities. Connectyx will be actively pursuing venture opportunities that will generate additional revenue, adding value to Connectyx through joint ventures and/or acquisitions with additional support from ESP Group.
Curative Biotechnology, Inc. OTC Markets
Equities
CUBT
US23128N1081
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0164 USD | +12.33% |
|
-6.29% | -23.00% |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 47.96B | |
+0.69% | 42.45B | |
+44.13% | 41.47B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- CUBT Stock
- CUBT Stock
- News Curative Biotechnology, Inc.
- Connectyx Seeks Acquisitions